Fabtech Technologies shares H1 FY26 earnings call transcript; revenue up 110%
FABTECH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 6.9 pts more than Nifty Microcap 250 and 7.3 pts more than its Medical Equipment & Supplies peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Fabtech Technologies reported H1 FY26 total income of INR19,322.80 lakhs, up 109.9% YoY, with net profit of INR2,198.02 lakhs, up 101.6%. EBITDA stood at INR2,839.99 lakhs with margins at 14.7%. Order book was INR90,441.87 lakhs as of July 2025, growing 7-9% by September. The company operates in 22 countries, focused on pharma turnkey projects in MENA and GCC regions. Management targets 20-25% sustained yearly growth but declined specific margin guidance, calling it a lumpy project business. An MOU with KP Group for sustainable energy was also disclosed.
Strong H1 with doubled revenue and profits. Order book provides growth visibility, but management evaded margin guidance, leaving investors to model on yearly trends.